• Explore /
  • Poster
  • / Real-world outcomes of docetaxel (DOC) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC): First analysis from an Italian multicenter observational study (ECHOS trial).

Real-world outcomes of docetaxel (DOC) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC): First analysis from an Italian multicenter observational study (ECHOS trial).

Abstract Poster

Authors

null

Orazio Caffo

Santa Chiara Hospital, Trento, Italy

Orazio Caffo , Umberto Basso , Nicolò Cavasin , Gaetano Facchini , Fabio Catalano , Maurizio Nicodemo , Mariella Sorarù , Paola Ermacora , Luca Galli , Carlo Cattrini , Nicolo Borsellino , Zuzana Sirotova , Sabrina Rossetti , Francesco Grillone , Paolo Andrea Zucali , Cinzia Ortega , Riccardo Ricotta , Francesca Valcamonico , Isabella Vittimberga , Consuelo Buttigliero

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 167)

DOI

10.1200/JCO.2023.41.6_suppl.167

Abstract #

167

Poster Bd #

F5

Abstract Disclosures

Similar Posters

First Author: Orazio Caffo

Poster

2024 ASCO Genitourinary Cancers Symposium

Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)

Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)

First Author: Benjamin L. Maughan

First Author: Prantik Das

First Author: Mehmet Asim Bilen